Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05186025 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tyrosine Allergoid Paediatric and Adult Study

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 30, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. 3 versions Re-verified since Dec 12, 2023, no change to tracked fieldsv3-v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this 5-year study is to demonstrate non-inferiority of children compared to adults by exploring long-term effectiveness after treatment with TA Bäume (trees) and TA Gräser (grass) following a perennial posology.
Trial Details
NCT Number NCT05186025
Lead Sponsor Allergy Therapeutics
Collaborators: Bencard Allergie GmbH
Conditions
(from sponsor)		 Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, Allergic Asthma
Related terms Conjunctivitis, Allergic, Hypersensitivity, Rhinitis, Allergic, Seasonal
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov